231 related articles for article (PubMed ID: 31705251)
41. Distinct pathophysiological cytokine profiles for discrimination between autoimmune pancreatitis, chronic pancreatitis, and pancreatic ductal adenocarcinoma.
Ghassem-Zadeh S; Gaida MM; Szanyi S; Acha-Orbea H; Frossard JL; Hinz U; Hackert T; Strobel O; Felix K
J Transl Med; 2017 Jun; 15(1):126. PubMed ID: 28578701
[TBL] [Abstract][Full Text] [Related]
42. Groove pancreatitis: a clinical and imaging overview.
Patel BN; Brooke Jeffrey R; Olcott EW; Zaheer A
Abdom Radiol (NY); 2020 May; 45(5):1439-1446. PubMed ID: 31559471
[TBL] [Abstract][Full Text] [Related]
43. Computerized tomography scan in pre-diagnostic pancreatic ductal adenocarcinoma: Stages of progression and potential benefits of early intervention: A retrospective study.
Singh DP; Sheedy S; Goenka AH; Wells M; Lee NJ; Barlow J; Sharma A; Kandlakunta H; Chandra S; Garg SK; Majumder S; Levy MJ; Takahashi N; Chari ST
Pancreatology; 2020 Oct; 20(7):1495-1501. PubMed ID: 32950386
[TBL] [Abstract][Full Text] [Related]
44. Utility of CT Radiomics Features in Differentiation of Pancreatic Ductal Adenocarcinoma From Normal Pancreatic Tissue.
Chu LC; Park S; Kawamoto S; Fouladi DF; Shayesteh S; Zinreich ES; Graves JS; Horton KM; Hruban RH; Yuille AL; Kinzler KW; Vogelstein B; Fishman EK
AJR Am J Roentgenol; 2019 Aug; 213(2):349-357. PubMed ID: 31012758
[No Abstract] [Full Text] [Related]
45. Pancreatic Ductal Adenocarcinoma and Its Variants: Pearls and Perils.
Schawkat K; Manning MA; Glickman JN; Mortele KJ
Radiographics; 2020; 40(5):1219-1239. PubMed ID: 32678699
[TBL] [Abstract][Full Text] [Related]
46. MRCP and MRI findings in 9 patients with autoimmune pancreatitis.
Kamisawa T; Chen PY; Tu Y; Nakajima H; Egawa N; Tsuruta K; Okamoto A; Kamata N
World J Gastroenterol; 2006 May; 12(18):2919-22. PubMed ID: 16718819
[TBL] [Abstract][Full Text] [Related]
47. Differentiation of focal autoimmune pancreatitis from pancreatic ductal adenocarcinoma.
Lopes Vendrami C; Shin JS; Hammond NA; Kothari K; Mittal PK; Miller FH
Abdom Radiol (NY); 2020 May; 45(5):1371-1386. PubMed ID: 31493022
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of Texture Analysis for the Differential Diagnosis of Mass-Forming Pancreatitis From Pancreatic Ductal Adenocarcinoma on Contrast-Enhanced CT Images.
Ren S; Zhang J; Chen J; Cui W; Zhao R; Qiu W; Duan S; Chen R; Chen X; Wang Z
Front Oncol; 2019; 9():1171. PubMed ID: 31750254
[No Abstract] [Full Text] [Related]
49. Repeatability and correlations of dynamic contrast enhanced and T2* MRI in patients with advanced pancreatic ductal adenocarcinoma.
Klaassen R; Gurney-Champion OJ; Wilmink JW; Besselink MG; Engelbrecht MRW; Stoker J; Nederveen AJ; van Laarhoven HWM
Magn Reson Imaging; 2018 Jul; 50():1-9. PubMed ID: 29476781
[TBL] [Abstract][Full Text] [Related]
50. Pitfalls in the MDCT of pancreatic cancer: strategies for minimizing errors.
Haj-Mirzaian A; Kawamoto S; Zaheer A; Hruban RH; Fishman EK; Chu LC
Abdom Radiol (NY); 2020 Feb; 45(2):457-478. PubMed ID: 31897686
[TBL] [Abstract][Full Text] [Related]
51. A case of stage IA pancreatic ductal adenocarcinoma accompanied with focal pancreatitis demonstrated by contrast-enhanced ultrasonography.
Fukuda J; Tanaka S; Ishida N; Ioka T; Ikezawa K; Takakura R; Nakao M; Ohkawa K; Katayama K; Nagata S
J Med Ultrason (2001); 2018 Oct; 45(4):617-622. PubMed ID: 29470686
[TBL] [Abstract][Full Text] [Related]
52. Mimicks of pancreatic malignancy in patients with chronic pancreatitis: correlation of computed tomography imaging features with histopathologic findings.
Oto A; Eltorky MA; Dave A; Ernst RD; Chen K; Rampy B; Chaljub G; Nealon W
Curr Probl Diagn Radiol; 2006; 35(5):199-205. PubMed ID: 16949476
[TBL] [Abstract][Full Text] [Related]
53. Differentiation between pancreatic carcinoma and mass-forming chronic pancreatitis: usefulness of high b value diffusion-weighted imaging.
Huang WC; Sheng J; Chen SY; Lu JP
J Dig Dis; 2011 Oct; 12(5):401-8. PubMed ID: 21955434
[TBL] [Abstract][Full Text] [Related]
54. The clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the differential diagnosis, staging, and response evaluation after concurrent chemoradiotherapy for pancreatic cancer.
Bang S; Chung HW; Park SW; Chung JB; Yun M; Lee JD; Song SY
J Clin Gastroenterol; 2006; 40(10):923-9. PubMed ID: 17063113
[TBL] [Abstract][Full Text] [Related]
55. Magnetic resonance cholangiopancreatography of pancreaticobiliary duct dilation due to pancreatic carcinoma and chronic pancreatitis.
Meng Z; Xu YK; Zhang YP
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jan; 28(1):113-5. PubMed ID: 18524063
[TBL] [Abstract][Full Text] [Related]
56. Clinical and radiologic characteristics of pancreatic head carcinoma without main pancreatic duct dilatation: using dual-phase contrast-enhanced CT scan.
Ko SE; Choi IY; Cha SH; Yeom SK; Lee SH; Chung HH; Hyun JJ
Clin Imaging; 2016; 40(3):548-52. PubMed ID: 27133702
[TBL] [Abstract][Full Text] [Related]
57. Comparison of diagnostic performance between CT and MRI in differentiating non-diffuse-type autoimmune pancreatitis from pancreatic ductal adenocarcinoma.
Lee S; Kim JH; Kim SY; Byun JH; Kim HJ; Kim MH; Lee MG; Lee SS
Eur Radiol; 2018 Dec; 28(12):5267-5274. PubMed ID: 29948075
[TBL] [Abstract][Full Text] [Related]
58. Missed pancreatic ductal adenocarcinoma: Assessment of early imaging findings on prediagnostic magnetic resonance imaging.
Jang KM; Kim SH; Kim YK; Song KD; Lee SJ; Choi D
Eur J Radiol; 2015 Aug; 84(8):1473-1479. PubMed ID: 26032128
[TBL] [Abstract][Full Text] [Related]
59. Paraduodenal pancreatitis: benign and malignant mimics at MRI.
Mittal PK; Harri P; Nandwana S; Moreno CC; Muraki T; Adsay V; Cox K; Pehlivanoglu B; Alexander LF; Chatterjee A; Miller FH
Abdom Radiol (NY); 2017 Nov; 42(11):2652-2674. PubMed ID: 28660333
[TBL] [Abstract][Full Text] [Related]
60. Factors associated with missed and misinterpreted cases of pancreatic ductal adenocarcinoma.
Kang JD; Clarke SE; Costa AF
Eur Radiol; 2021 Apr; 31(4):2422-2432. PubMed ID: 32997176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
